Hormone and Metabolic Research

LinksSchließen

Referenz

Sheppard M, Bronstein MD, Freda P. et al.
Pasireotide LAR maintains inhibition of GH and IGF-1 in patients with acromegaly for up to 25 months: results from the blinded extension phase of a randomized, double-blind, multicenter, Phase III study.

Pituitary 2014;
18: 385-394

Bibliographische Angaben herunterladen

Suchen in: